Literature DB >> 2693517

Thoracic stimulation and prolactin secretion.

L P Kapcala1, M C Lakshmanan.   

Abstract

Although galactorrhea and/or enhanced prolactin (PRL) secretion have been reported with a variety of thoracic stimuli, the effect of thoracic stimulation on dynamic prolactin secretion is not clear. A 49-year-old woman with ventilatory muscle weakness from polio presented with galactorrhea, and intermittent hyperprolactinemia but regular menses. The galactorrhea was noted following the use of a new, tight fitting cuirass (thoracic apparatus which assists ventilation). To determine if the new, "tight" cuirass elicited enhanced PRL secretion, and to assess more extensively the effect of such thoracic stimulation on PRL secretion, serum PRL was measured during brief and prolonged stimulation, sleep, and pharmacological manipulation of PRL. Basal PRL was normal (less than 25 ng/ml) and increased during brief stimulation (1 hour) with the "tight" (137%) and "loose" cuirass (140%). Although the absolute increments were similar, the "tight" cuirass elicited an earlier PRL peak than the "loose" cuirass and the PRL began to decrease while the "tight" cuirass was still functioning. Several hours of thoracic stimulation resulted in a transient rise in PRL and a fall to normal, prestimulatory levels despite persistent stimulation. During this stimulation, PRL did not rise after sleep nor after insulin-induced hypoglycemia despite normal cortisol and GH increments, but the PRL response after TRH was exaggerated.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2693517     DOI: 10.1007/BF03350070

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  40 in total

1.  Non-puerperal galactorrhea; with case reports.

Authors:  E G GRIMM
Journal:  Q Bull Northwest Univ Med Sch       Date:  1955

2.  Prolactin release during nursing and breast stimulation in postpartum and nonpostpartum subjects.

Authors:  G L Noel; H K Suh; A G Frantz
Journal:  J Clin Endocrinol Metab       Date:  1974-03       Impact factor: 5.958

3.  Evidence that the depletion and release phases of prolactin secretion in the lactating rat have different activation thresholds in response to exteroceptive stimulation from rat pups.

Authors:  C E Grosvenor; N S Whitworth; F Mena
Journal:  Endocrinology       Date:  1981-03       Impact factor: 4.736

4.  Role of pup age, estradiol-17 beta and pituitary responsiveness in the differences in the suckling-induced prolactin response during early and late lactation.

Authors:  M Selmanoff; C Selmanoff
Journal:  Biol Reprod       Date:  1983-09       Impact factor: 4.285

5.  Response of serum prolactin to exogenous stimulation.

Authors:  D F Archer; J B Josimovich
Journal:  Fertil Steril       Date:  1975-07       Impact factor: 7.329

6.  Galactorrhoea, amenorrhoea and hyperprolactinaemia after an operation on the breast: A case report.

Authors:  M P Sandler; M B Forman; R Lopis; W J Kalk
Journal:  S Afr Med J       Date:  1980-01-19

7.  Section of the pituitary stalk in the rhesus monkey. I. Endocrine studies.

Authors:  L Vaughan; P W Carmel; I Dyrenfurth; A G Frantz; J L Antunes; M Ferin
Journal:  Neuroendocrinology       Date:  1980       Impact factor: 4.914

8.  Galactorrhea: a study of 235 cases, including 48 with pituitary tumors.

Authors:  D L Kleinberg; G L Noel; A G Frantz
Journal:  N Engl J Med       Date:  1977-03-17       Impact factor: 91.245

9.  Galactorrhea and hyperprolactinemia associated with chest wall injury.

Authors:  J E Morley; M Dawson; H Hodgkinson; W J Kalk
Journal:  J Clin Endocrinol Metab       Date:  1977-11       Impact factor: 5.958

10.  Neurogenic galactorrhea-amenorrhea.

Authors:  A E Boyd; S Spare; B Bower; S Reichlin
Journal:  J Clin Endocrinol Metab       Date:  1978-12       Impact factor: 5.958

View more
  1 in total

Review 1.  Treatment of Prolactinoma.

Authors:  Warrick J Inder; Christina Jang
Journal:  Medicina (Kaunas)       Date:  2022-08-13       Impact factor: 2.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.